NO20073167L - Skjaerbeskyttende midler for isolering ved mikrofiltrering - Google Patents

Skjaerbeskyttende midler for isolering ved mikrofiltrering

Info

Publication number
NO20073167L
NO20073167L NO20073167A NO20073167A NO20073167L NO 20073167 L NO20073167 L NO 20073167L NO 20073167 A NO20073167 A NO 20073167A NO 20073167 A NO20073167 A NO 20073167A NO 20073167 L NO20073167 L NO 20073167L
Authority
NO
Norway
Prior art keywords
microfiltration
insulation
protection agents
cutting protection
diafiltration
Prior art date
Application number
NO20073167A
Other languages
English (en)
Inventor
James Pierce
Enda Moran
Original Assignee
Wyeth Res Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36791010&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073167(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Res Ireland Ltd filed Critical Wyeth Res Ireland Ltd
Publication of NO20073167L publication Critical patent/NO20073167L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/16—Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/147—Microfiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/12—Addition of chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/16—Flow or flux control
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Housing For Livestock And Birds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Tilsetningen av buffer til en isoleringsstrøm under diafiltrering kan forårsake økt turbiditet og ha andre uønskede effekter, inklusivt begrenset produktgjenvinning. Fremgangsmåter og sammensetninger med relasjon til anvendelsen av en ikke-ionisk surfaktant for forbedret diafiltrering er beskrevet.
NO20073167A 2005-01-25 2007-06-22 Skjaerbeskyttende midler for isolering ved mikrofiltrering NO20073167L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64718405P 2005-01-25 2005-01-25
PCT/IB2006/001231 WO2006087643A2 (en) 2005-01-25 2006-01-24 Method for diafiltration

Publications (1)

Publication Number Publication Date
NO20073167L true NO20073167L (no) 2007-09-27

Family

ID=36791010

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073167A NO20073167L (no) 2005-01-25 2007-06-22 Skjaerbeskyttende midler for isolering ved mikrofiltrering

Country Status (19)

Country Link
US (1) US7906024B2 (no)
EP (1) EP1841474A2 (no)
JP (1) JP5312799B2 (no)
KR (1) KR101337311B1 (no)
CN (1) CN101107022B (no)
AR (1) AR057263A1 (no)
AU (1) AU2006215313B2 (no)
BR (1) BRPI0607269A2 (no)
CA (1) CA2594580C (no)
CR (1) CR9212A (no)
GT (1) GT200600027A (no)
IL (1) IL184247A (no)
MX (1) MX2007008777A (no)
NI (1) NI200700153A (no)
NO (1) NO20073167L (no)
PE (1) PE20060958A1 (no)
RU (1) RU2442822C2 (no)
TW (1) TW200634145A (no)
WO (1) WO2006087643A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111022A1 (en) * 2008-03-07 2009-09-11 Corning Incorporated Hydrophobically modified cellulose ether derivatives for cell culture and release
CA2750263C (en) * 2009-01-21 2018-03-20 Smartflow Technologies, Inc. Optimization of separation for viscous suspensions
EP2424647B1 (de) * 2009-04-29 2018-04-18 Basf Se Verfahren zur ausschleusung und konditionierung von katalysatoren mittels membranfiltration
JP2013517771A (ja) * 2010-01-22 2013-05-20 ロンザ ウォーカーズヴィル，インコーポレーテッド タンジェンシャルフローフィルトレーションを用いた治療用細胞の容量減少および洗浄のための高収率法および装置
WO2015010097A2 (en) * 2013-07-19 2015-01-22 Circle Technologies, Inc. Systems and methods for bioprocess analysis
KR102695908B1 (ko) * 2016-07-21 2024-08-14 스파크 테라퓨틱스, 인코포레이티드 재조합 아데노-관련 바이러스(rAAV) 벡터를 고수율로 생산하기 위한 확장 가능한 고회수 방법 및 이에 의해 생산된 재조합 아데노-관련 바이러스(rAAV) 벡터
US20230287335A1 (en) * 2020-07-30 2023-09-14 Amgen Inc. Cell culture media and methods of making and using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707542A (en) * 1983-08-22 1987-11-17 Merck & Co., Inc. Immunogenic HbsAg derived from transformed yeast
DE3515650A1 (de) * 1985-05-02 1986-11-06 Biochemie GmbH, Kundl, Tirol Verfahren zur abtrennung von biotechnologisch hergestellten wertstoffen durch querstrom-mikrofiltration
US5336603A (en) * 1987-10-02 1994-08-09 Genentech, Inc. CD4 adheson variants
DE4204700A1 (de) * 1992-02-17 1993-08-19 Henkel Kgaa Verfahren zur abtrennung anorganischer salze
CN1038512C (zh) * 1992-10-20 1998-05-27 空军第四研究所 促肝细胞生长素生产方法
US5681746A (en) * 1994-12-30 1997-10-28 Chiron Viagene, Inc. Retroviral delivery of full length factor VIII
US5597486A (en) * 1995-05-01 1997-01-28 Millipore Investment Holdings Limited Membrane filtration with optimized addition of second liquid to maximize flux
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6436897B2 (en) * 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
US6245568B1 (en) 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
AU783918B2 (en) * 1999-11-19 2005-12-22 Eisai Inc. Continuous-flow method for preparing microparticles
GB2364052B (en) * 2000-06-27 2003-05-14 Univ London A method and apparatus for producing a biomaterial product
JP2002066273A (ja) * 2000-09-01 2002-03-05 Terumo Corp 中空糸膜の酸化抑制方法
US20050164929A1 (en) * 2000-11-06 2005-07-28 Lupine Logic, Inc. Methods of preventing and treating inflammatory bowel disease
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
JP3815351B2 (ja) * 2002-03-12 2006-08-30 栗田工業株式会社 糖液精製装置及び糖液精製方法
CA2498518A1 (en) * 2002-09-13 2004-03-25 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
CA2504134C (en) * 2002-11-01 2012-03-06 Bayer Healthcare Llc Process for concentration of macromolecules
AU2004249802B2 (en) * 2003-06-20 2007-06-28 Microbix Biosystems Inc. Improvements in virus production
US20060083694A1 (en) * 2004-08-07 2006-04-20 Cabot Corporation Multi-component particles comprising inorganic nanoparticles distributed in an organic matrix and processes for making and using same
EP1828224B1 (en) * 2004-12-22 2016-04-06 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides

Also Published As

Publication number Publication date
PE20060958A1 (es) 2006-10-27
RU2007122451A (ru) 2009-03-10
KR20070101285A (ko) 2007-10-16
CA2594580A1 (en) 2006-08-24
NI200700153A (es) 2008-05-13
IL184247A (en) 2014-08-31
EP1841474A2 (en) 2007-10-10
CN101107022A (zh) 2008-01-16
RU2442822C2 (ru) 2012-02-20
JP5312799B2 (ja) 2013-10-09
JP2008528273A (ja) 2008-07-31
US7906024B2 (en) 2011-03-15
CR9212A (es) 2007-11-23
BRPI0607269A2 (pt) 2009-08-25
IL184247A0 (en) 2007-10-31
WO2006087643A3 (en) 2006-11-09
AR057263A1 (es) 2007-11-28
CN101107022B (zh) 2013-07-17
MX2007008777A (es) 2007-10-23
WO2006087643A2 (en) 2006-08-24
AU2006215313B2 (en) 2011-11-24
KR101337311B1 (ko) 2013-12-06
TW200634145A (en) 2006-10-01
AU2006215313A1 (en) 2006-08-24
GT200600027A (es) 2006-08-31
US20060194313A1 (en) 2006-08-31
CA2594580C (en) 2013-09-24

Similar Documents

Publication Publication Date Title
NO20073167L (no) Skjaerbeskyttende midler for isolering ved mikrofiltrering
EA201270716A1 (ru) Макроциклы в качестве ингибиторов фактора xia
EP1924593B8 (en) Hcv ns3 protease inhibitors
MX2011009644A (es) Inhibidores del virus de la hepatitis c.
WO2010029302A3 (en) Compounds for treating viral infections
TW200504203A (en) Compositions and methods for high-efficiency cleaning of semiconductor wafers
NO20073098L (no) Substituerte biarylforbindelser som faktor XIa-Inhibitorer
NO20074959L (no) Substituerte pyridinderivater
WO2006119061A3 (en) Hcv ns3 protease inhibitors
EA200702340A1 (ru) Противообледенительная и/или антиобледенительная композиция, способ ее получения, жидкое средство для понижения температуры замерзания на ее основе и способ удаления и/или предотвращения образования льда
NO20072918L (no) Heteroaromatiske quinolinforbindelser, og anvendelse av disse som inhibitorer av PDE10
WO2008057208A3 (en) Hcv ns3 protease inhibitors
WO2006104945A3 (en) Hepatitis c therapies
CY1114310T1 (el) Νεες ανοσοενισχυτικες συνθεσεις γλυκολιπιδιου
MX2013002927A (es) Inhibidores del virus de la hepatitis c.
MX2009002740A (es) Inhibidores de renina.
WO2010053573A3 (en) Screen for inhibitors of filovirus and uses therefor
WO2008075376A8 (en) Polymorphic forms of bortezomib and process for their preparation
MX2010004704A (es) Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c.
DK1828297T3 (da) Fremstilling og behandling af bitumensammensætninger
CY1114562T1 (el) Υψηλης καθαροτητας μεγαλης κλιμακας παρασκευη στανσοπορφινης
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
IL196811A0 (en) Salts of benzimidazolyl pyridyl ethers and formulations thereof
WO2010056585A3 (en) Heteroaryl diamide compounds useful as mmp-13 inhibitors
NO20073276L (no) Metode for fremstilling av aminoetoksybenzylalkoholer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application